Skip to main content

Videos

Insights into the Prostate Cancer Imaging Landscape

Insights into the Prostate Cancer Imaging Landscape

FEATURING:

Steven Rowe, MD, PhD

February 15, 2022

Interview with the Innovators

Results from the OSPREY Trial in Pre-Prostatectomy Patients

Results from the OSPREY Trial in Pre-Prostatectomy Patients

FEATURING:

Steven Rowe, MD, PhD

February 8, 2022

Interview with the Innovators

PYLARIFY Imaging in High-Risk Prostate Cancer

PYLARIFY Imaging in High-Risk Prostate Cancer

FEATURING:

Steven Rowe, MD, PhD

February 1, 2022

Interview with the Innovators

Overview of the Molecular Characteristics of PYLARIFY

Overview of the Molecular Characteristics of PYLARIFY

FEATURING:

Steven Rowe, MD, PhD

January 26, 2022

Interview with the Innovators

Managing Cost and Patient Risk for Optimal Value-Based Care

Managing Cost and Patient Risk for Optimal Value-Based Care

FEATURING:

Ajeet Gajra, MD; Brandy Manning; Tanya Park

December 8, 2021

The Importance of Accurate Staging in Prostate Cancer

The Importance of Accurate Staging in Prostate Cancer

FEATURING:

Neal Shore, MD, FACS

November 24, 2021

Interview with the Innovators

Use of PYLARIFY® in Specific Patient Groups

Use of PYLARIFY® in Specific Patient Groups

FEATURING:

Neal Shore, MD, FACS

November 23, 2021

Interview with the Innovators

PSMA PET Imaging in Patients with Oligometastatic Prostate Cancer

PSMA PET Imaging in Patients with Oligometastatic Prostate Cancer

November 15, 2021

Interview with the Innovators

PYLARIFY and Next-Generation Imaging

PYLARIFY and Next-Generation Imaging

FEATURING:

Neal Shore, MD, FACS

November 8, 2021

Interview with the Innovators

Page 7 of 20